Nilotinib in Huntington's Disease
NCT03764215
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Huntington Disease
Interventions
DRUG:
Nilotinib 150 MG
Sponsor
Georgetown University